Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 46, 2011 - Issue 6
Submit an article Journal homepage
208
Views
13
CrossRef citations to date
0
Altmetric
Liver and biliary disease

Overweight and hypertriglyceridemia are risk factors for liver cirrhosis in middle-aged Swedish men

Andreas SchultDepartment of Medicine, Sahlgrenska University Hospital Östra, Gothenburg, SwedenCorrespondence[email protected]
,
Henry ErikssonDepartment of Medicine, Sahlgrenska University Hospital Östra, Gothenburg, Sweden
,
Sven WallerstedtDepartment of Medicine, Sahlgrenska University Hospital Östra, Gothenburg, Sweden
&
Jerzy KaczynskiDepartment of Medicine, Sahlgrenska University Hospital Östra, Gothenburg, Sweden
Pages 738-744 | Received 27 Nov 2010, Accepted 02 Feb 2011, Published online: 28 Feb 2011

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Andreas Schult, Kirsten Mehlig, Cecilia Björkelund, Sven Wallerstedt & Jerzy Kaczynski. (2018) Waist-to-hip ratio but not body mass index predicts liver cirrhosis in women. Scandinavian Journal of Gastroenterology 53:2, pages 212-217.
Read now
Kristian Bjøro. (2011) This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 46:6, pages 643-644.
Read now

Articles from other publishers (11)

Yu Zeng, Xuemei Zhang, Wenling Luo & Yunjian Sheng. (2023) Effect of exercise intervention on clinical parameters in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. European Journal of Gastroenterology & Hepatology.
Crossref
Youn Huh, Yoon Jeong Cho & Ga Eun Nam. (2022) Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease. Journal of Obesity & Metabolic Syndrome 31:1, pages 17-27.
Crossref
Amedeo Lonardo, Juan Pablo Arab & Marco Arrese. (2021) Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management. Advances in Therapy 38:5, pages 2130-2158.
Crossref
Helen Jarvis, Dawn Craig, Robert Barker, Gemma Spiers, Daniel Stow, Quentin M. Anstee & Barbara Hanratty. (2020) Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies. PLOS Medicine 17:4, pages e1003100.
Crossref
Stefano Ballestri, Alessandro Mantovani, Fabio Nascimbeni, Simonetta Lugari & Amedeo Lonardo. (2019) Extra-hepatic manifestations and complications of nonalcoholic fatty liver disease. Future Medicinal Chemistry 11:16, pages 2171-2192.
Crossref
Umair Iqbal, Brandon Perumpail, Daud Akhtar, Donghee Kim & Aijaz Ahmed. (2019) The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease. Medicines 6:1, pages 41.
Crossref
Omar Ramos-Lopez, Arturo Panduro, Ingrid Rivera-Iñiguez & Sonia Roman. (2018) Dopamine D2 receptor polymorphism (C957T) is associated with sugar consumption and triglyceride levels in West Mexicans. Physiology & Behavior 194, pages 532-537.
Crossref
Omar Ramos-Lopez, Arturo Panduro, Erika Martinez-Lopez & Sonia Roman. (2016) Sweet Taste Receptor TAS1R2 Polymorphism (Val191Val) Is Associated with a Higher Carbohydrate Intake and Hypertriglyceridemia among the Population of West Mexico. Nutrients 8:2, pages 101.
Crossref
Amedeo Lonardo, Stefano Bellentani, Curtis K. Argo, Stefano Ballestri, Christopher D. Byrne, Stephen H. Caldwell, Helena Cortez-Pinto, Antonio Grieco, Mariana V. Machado, Luca Miele & Giovanni Targher. (2015) Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups. Digestive and Liver Disease 47:12, pages 997-1006.
Crossref
Allen M. Klein. (2013) Life insurance underwriting in the United States – yesterday, today and tomorrow. British Actuarial Journal 18:2, pages 486-502.
Crossref
Mauro Maurantonio, Stefano Ballestri, Maria Rosaria Odoardi, Amedeo Lonardo & Paola Loria. (2011) Treatment of Atherogenic Liver Based on the Pathogenesis of Nonalcoholic Fatty Liver Disease: A Novel Approach to Reduce Cardiovascular Risk?. Archives of Medical Research 42:5, pages 337-353.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.